Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study.

Crosignani, A; Budillon, G; Cimino, L; Del Vecchio Blanco, C; Loguercio, C; Ideo, G; Raimondo, G; Stabilini, R; Podda, M

Crosignani, A; Budillon, G; Cimino, L; Del Vecchio Blanco, C; Loguercio, C; Ideo, G; Raimondo, G; Stabilini, R; Podda, M.

Affiliation

Crosignani A; Division of Internal Medicine, School of Medicine San Paolo, Milan, Italy.

Hepatogastroenterology ; 45(23): 1624-9, 1998.

Article in En | MEDLINE | ID: mdl-9840118

Subject(s)

Hepatitis C, Chronic/drug therapy; Taurochenodeoxycholic Acid/therapeutic use; Alanine Transaminase/blood; Aspartate Aminotransferases/blood; Clinical Enzyme Tests; Double-Blind Method; Female; Hepatitis C, Chronic/diagnosis; Humans; Male; Middle Aged; gamma-Glutamyltransferase/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Taurochenodeoxycholic Acid / Hepatitis C, Chronic Type of study: Clinical_trials / Diagnostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Hepatogastroenterology Year: 1998 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links